According to a March 4 proposal, the new "Aavenomics" implementation would include an Aave buyback and distribution program.

Tariffs could increase builder costs anywhere from $7,500 to $10,000 per home, according to the chief economist of the National Association of Home Builders.

Ventas's VTR short percent of float has fallen 14.65% since its last report. The company recently reported that it has 10.96 million shares sold short, which is 3.32% of all regular shares that are available for trading. Based on its trading volume, it would take traders 4.27 days to cover their ...

Applied Optoelectronics's AAOI short percent of float has fallen 8.65% since its last report. The company recently reported that it has 8.72 million shares sold short, which is 18.37% of all regular shares that are available for trading.

TPG's TPG short percent of float has risen 14.78% since its last report. The company recently reported that it has 4.58 million shares sold short, which is 4.66% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.8 days to cover their short ...

The great buildout for AI and GLP-1 drugs continues.

Shares of Deere & Co. ( NYSE: DE ) fell as much as 3.9% this morning as investor sentiment took a double blow. An analyst downgraded the agricultural machinery stock, citing valuation concerns, even as President Donald Trump announced tariffs on "external" agricultural products effective April 2.

Pliant Therapeutics halted its Phase 2b trial for bexotegrast in IPF, raising concerns about future prospects. Needham downgraded Pliant to Hold from Buy, citing a lack of near-term catalysts and a thin early-stage pipeline.

PepGen paused its Phase 2 CONNECT2 study of PGN-EDO51 in DMD to review 10 mg/kg cohort data from CONNECT1, expected in Q3 2025. No new safety concerns have emerged and the company aims to refine CONNECT2 design based on upcoming dystrophin level assessments.

JP Morgan analyst lowers GitLab's price target to $62, citing balanced risk-reward despite strong earnings and revenue beat. GitLab's Q1 guidance reflects stable outlook, with no adjustments for macro changes or public sector risks, analyst notes.